Related Experiment Video
Updated: Aug 29, 2025

A Modified Trier Social Stress Test for Vulnerable Mexican American Adolescents
Published on: July 10, 2017
Depression is differentially related to cognitive and biomarker outcomes among Mexican Americans
Sid E O'Bryant1, Melissa Petersen1,2, James Hall1
1Institute for Translational Research, University of North Texas Health Science Center, Fort Worth, TX, United States.
Introduction:
Despite tremendous advancements in the research of Alzheimer's disease (AD), Mexican Americans, who reflect 65% of the US Hispanic community, remain severely underrepresented in research. Our data demonstrate that risk factors for, and biomarkers of, AD are different among Mexican Americans as compared with non-Hispanic whites. Here, we examined the impact of depressive symptoms on cognitive and AD-relevant biomarker outcomes among the Mexican Americans.
Methods:
Data were examined from 1,633 (852 Mexican Americans and 781 non-Hispanic whites) of the Health and Aging Brain Study-Health Disparities (HABS-HD). Depression was assessed using the Geriatric Depression Scale while cognition was measured using detailed neuropsychological testing. Plasma biomarkers of Aβ40, Aβ42, total tau, and NfL were examined in addition to MRI-based neurodegeneration. PET amyloid data were available in a subset of participants.
Results:
Depressive symptoms were significantly associated with cognitive testing results among both Mexican Americans and non-Hispanic whites. However, depression was only significantly associated with cognitive outcomes and plasma biomarkers among the Mexican American APOEε4 non-carriers.
Discussion:
Depressive symptoms are more commonly endorsed by Mexican Americans and these symptoms are more strongly associated with cognitive and AD-biomarker outcomes among this ethnic group. However, depression scores were only related to AD outcomes among APOEε4 non-carriers within the Mexican American group. These findings can aid in the development of a population-informed precision medicine for treating and preventing cognitive loss among the Mexican Americans.
Insights
Depressive symptoms impact cognitive and Alzheimer's disease (AD) biomarkers differently in Mexican Americans compared to non-Hispanic whites. These symptoms are more strongly linked to AD outcomes in Mexican American non-carriers of the APOEε4 gene variant.
Area of Science:
- Neuroscience
- Gerontology
- Public Health
Background:
- Alzheimer's disease (AD) research significantly underrepresents Mexican Americans, a key demographic within the US Hispanic community.
- Existing data suggest distinct AD risk factors and biomarkers in Mexican Americans compared to non-Hispanic whites.
- Understanding ethnic-specific variations in AD is crucial for developing targeted interventions.
Purpose of the Study:
- To investigate the influence of depressive symptoms on cognitive function and AD-related biomarkers in Mexican Americans.
- To compare these associations between Mexican Americans and non-Hispanic whites.
- To identify potential ethnic-specific patterns in AD pathology.
Main Methods:
- Analysis of data from 1,633 participants (852 Mexican Americans, 781 non-Hispanic whites) in the Health and Aging Brain Study-Health Disparities (HABS-HD).
- Assessment of depressive symptoms using the Geriatric Depression Scale.
- Measurement of cognitive function via neuropsychological testing, plasma biomarkers (Aβ40, Aβ42, tau, NfL), and neuroimaging (MRI, PET amyloid).
Main Results:
- Depressive symptoms showed significant associations with cognitive test results in both Mexican Americans and non-Hispanic whites.
- In Mexican Americans, depression was significantly linked to cognitive outcomes and plasma biomarkers only among individuals who were not carriers of the APOEε4 gene variant.
- These findings highlight a differential impact of depression on AD-related markers within this ethnic group.
Conclusions:
- Depressive symptoms are more prevalent and more strongly associated with cognitive and AD biomarker outcomes in Mexican Americans.
- The association between depression and AD outcomes is specifically observed in Mexican American non-carriers of the APOEε4 gene.
- These results support the development of precision medicine approaches tailored to the unique needs of the Mexican American population for cognitive health.
More Related Videos
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
06:55An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
Published on: December 2, 2015
Related Concept Videos
Depression: Overview
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Depressive Disorders: MDD and Dysthymia
Cognitive Therapy
Long-term Depression
Calcium Ion Concentration Mechanism
If over...